A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs Response

被引：0
|
作者：
Papamichael, Konstantinos [1 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 12期
关键词：
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INFLIXIMAB; IBD;
D O I：
10.1038/ajg.2017.375
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1893 / 1894
页数：2
相关论文
共 50 条
  • [21] Predictors of response and anti-TNF drugs comparative efficacy
    Helena Canhão
    Ana F Mourão
    Fernando Martins
    Maria J Santos
    Canas Silva
    Joaquim Pereira
    JA Pereira Silva
    José Costa
    Domingos Araujo
    Candida Silva
    Eugenia Simões
    Catia Duarte
    José Antonio P Silva
    Fernando Pimentel
    Jaime Branco
    João E Fonseca
    Journal of Translational Medicine, 9 (Suppl 2)
  • [22] Rationale for therapeutic drug monitoring (TDM) of anticancer drugs
    Boddy, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 8 - 8
  • [23] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [24] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [25] Spondylarthropathies and anti-TNFα drugs
    Pavy, S
    Allanore, Y
    Kahan, A
    REVUE DE MEDECINE INTERNE, 2005, 26 (09): : 717 - 724
  • [26] Therapeutic Drug Monitoring of the Infliximab (anti-TNF) Level with Bedside Kit in Inflammatory Bowel Disease
    Gur, M. B.
    Bakkaloglu, O. K.
    Eskazan, T.
    Akpinar, A.
    Hatemi, A., I
    Erzin, Y. Z.
    Celik, A. F.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1331 - i1331
  • [27] Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
    Eun, Chang Soo
    GUT AND LIVER, 2017, 11 (01) : 3 - 4
  • [28] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
  • [29] AN INDIAN NATIONAL SURVEY OF THERAPEUTIC DRUG MONITORING WITH ANTI-TNF MEDICATIONS IN INFLAMMATORY BOWEL DISEASE
    Nigam, Gaurav B.
    Patel, Rajan N.
    Jatale, Raj G.
    Makharia, Govind K.
    Ahuja, Vineet
    Desai, Devendra
    Limdi, Jimmy K.
    GASTROENTEROLOGY, 2020, 158 (06) : S246 - S246
  • [30] Editorial: is it time for therapeutic drug monitoring of anti-TNF agents during pregnancy? Maybe, maybe not
    Kane, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1555 - 1556
12345